HT
NVAX icon

Headlands Technologies’s Novavax NVAX Stock Holding History

Headlands Technologies’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Buy
190,547
+872
+0.5% +$7.81K 0.19% 130
2026
Q1 		$1.54M Buy
189,675
+89,392
+89% +$810K 0.18% 120
2025
Q4 		$674K Sell
100,283
-222,747
-69% -$1.68M 0.06% 345
2025
Q3 		$2.8M Buy
323,030
+179,664
+125% +$1.4M 0.22% 104
2025
Q2 		$903K Buy
+143,366
New +$949K 0.11% 201
2024
Q2 		– Sell
-55,137
Closed -$264K – 1467
2024
Q1 		$264K Buy
55,137
+50,480
+1,084% +$234K 0.06% 307
2023
Q4 		$22.4K Buy
+4,657
New +$28.5K 0.01% 655

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Headlands Technologies's NVAX Position: Q2 2026 in Review

Headlands Technologies increased its Novavax (NVAX) stake by 0.46% in Q2 2026, buying an estimated $7.81K and bringing the position to 190,547 shares worth $1.79M. The position accounts for 0.19% of the portfolio, ranked #130.

Headlands Technologies first reported a position in NVAX in Q4 2023 and has held it in 7 quarters since. The position peaked at $2.8M in Q3 2025. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Headlands Technologies held 190,547 shares of Novavax worth $1.79M as of Q2 2026.
  • Headlands Technologies bought 872 Novavax shares in Q2 2026, an estimated $7.81K.
  • Novavax made up 0.19% of Headlands Technologies's portfolio in Q2 2026, its #130 holding.
  • Headlands Technologies first reported a position in Novavax in Q4 2023 and has held it in 7 quarters since.
  • Headlands Technologies's Novavax position peaked at $2.8M in Q3 2025.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.